Meeker David P
President and CEO
Meeker David P has filed 3 SEC Form 4 filings (9 transaction rows) across 2 companies, including RYTM, KARD, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Meeker David P is listed as President and CEO at RHYTHM PHARMACEUTICALS, INC. Inside the rolling window, Meeker David P reported no open-market purchases and 1 open-market sale totaling $5.1M in RYTM.
Companies traded
Other insiders at RYTM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.1M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Meeker David P made?
Meeker David P has filed 3 SEC Form 4 filings (9 transaction rows) across 2 companies, including RYTM, KARD since 2026.
Which companies does Meeker David P trade?
Meeker David P has filed SEC Form 4 disclosures for 2 companies, including RYTM, KARD.
When was Meeker David P's most recent SEC Form 4 filing?
Meeker David P's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Meeker David P's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Meeker David P is listed as President and CEO.
What is Meeker David P's total buy and sell value in the current window?
Inside the rolling retention window, Meeker David P bought $0 and sold $5.1M based on SEC Form 4 filings.
What was Meeker David P's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 RYTM shares on 2026-09-14, worth $5.1M, per SEC Form 4 filings.